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ABSTRACT 
Hyperpolarization by dissolution dynamic nuclear polarization (DNP) is a 
versatile technique to dramatically enhance the nuclear magnetic resonance 
(NMR) signal intensity of insensitive long-T1 nuclear spins such as 
6
Li. The 
6
Li 
longitudinal relaxation of lithium ions in aqueous solutions highly depends on the 
concentration of paramagnetic species, even if they are present in minute 
amounts. We herein demonstrate that blood oxygenation can be readily detected 
by taking advantage of the 
6
Li signal enhancement provided by dissolution DNP 
together with the more than 10% decrease in 
6
Li longitudinal relaxation as a 
consequence of the presence of paramagnetic deoxyhemoglobin. 
INTRODUCTION 
Oxygen delivery and consumption correlate with the physiological state of tissues and 
organs and affect their metabolism. Pathological situations are characterized by 
variations in oxygenation levels (1,2), which may directly affect treatment and 
recovery (3,4). Oxygen uptake can be measured by positron emission tomography 
(PET) imaging following the inhalation of 
15
O2. However the short 
15
O half-life (2.1 
min) limits its availability as it requires the need of an onsite cyclotron, and the use of 
ionizing radiation restricts the number of examinations per patient (5). Alternatively, 
the stable 
17
O isotope can be used to probe oxygen metabolism by magnetic resonance 
(MR). Unlike 
15
O PET, 
17
O MR offers the advantage to selectively measure the 
metabolically generated H2
17
O without confounding signals from the 
17
O2 molecules 
bound to hemoglobin. However, the low gyromagnetic ratio of 
17
O (5.77 MHz/T) and 
the short associated T2
*
 relaxation time (~2 ms) leads to low sensitivity (6). A 
different MR method for mapping oxygenation level is based on the blood 
oxygenation level dependent (BOLD) contrast which relies on the effect of 
paramagnetic deoxyhemoglobin on proton transverse relaxation (7). Although BOLD 
MR imaging is mostly known in the context of cognitive neuroscience as functional 
3 
MRI, recent studies have shown that it can be used to map hypoxic regions in tumors 
(8). The major drawback of this T2
*
-weighted imaging approach lies in the 
dependence of T2* on many other parameters other than the oxygen level, including 
magnetic field inhomogeneities, water diffusion, and the structure of the blood vessel 
network including blood volume, which may represent confounding variables (9). 
The recently developed dissolution dynamic nuclear polarization (DNP) technique 
enables hyperpolarizing nuclear spins of molecules in solutions that can be injected 
into cell suspensions, perfused organs, animals or humans (10). The large signal 
resulting from the dramatic increase in polarization allows detecting in real time the 
biodistribution and the metabolism of molecules containing nuclear spins with long 
longitudinal relaxation times (11-13). Consequently, DNP-enhanced MR studies have 
been so far mostly restricted to precursors with non-protonated spin-½ nuclei such as 
13
C-labeled carbonyls or 
15
N-labeled quaternary amines. However, it has been shown 
that 
6
Li, a spin-1 nucleus with an exceptionally small quadrupole moment (Q<8.5 
kHz), can also be hyperpolarized using dissolution DNP and that hyperpolarized 
6
Li 
can be detected in vivo in the rat brain (14). The 
6
Li longitudinal relaxation time of 
Li
+
 ions can be as long as 550 s when dissolved in deoxygenated deuterated water 
(D2O) at room temperature (15).   
A recent study showed that, following the intraperitoneal administration of lithium to 
rodents, a large fraction of the Li
+
 ions incorporated into the brain is located in the 
intracellular compartment (16). Hyperpolarized 
6
Li could therefore be an interesting 
contrast media for perfusion imaging with similar methods than the ones proposed 
with hyperpolarized xenon (17), and hyperpolarized 
13
C tert-butanol (18). More 
generally, the potential of hyperpolarized 
6
Li as contrast agent for molecular imaging 
is high because Li
+
 ions can replace the ubiquitous and essential Na
+
 ions in many 
biological systems. It was previously shown that the 
6
Li T1 of Li
+
 ions in solutions is 
remarkably sensitive to the presence of paramagnetic species and that hyperpolarized 
4 
6
Li could be used as a sensor for traces amount (< mM) of Gd-based MR contrast 
agents (14). The aim of the present study was to detect blood oxygenation level in 
human and rat blood and plasma using hyperpolarized 
6
Li.  
RESULTS 
To determine the effect of hemoglobin oxygenation on the T1 of 
6
Li, we 
simultaneously measured the decay of the hyperpolarized
 6
Li signal in three separated 
tubes, two of them (tubes #1 and #3) containing either whole blood and deoxygenated 
blood or plasma and deoxygenated plasma, and the third one (tube #2) containing 
D2O (99.6% D) to obtain a reference relaxation measurement (Fig. 1). To separate the 
signal originating from each one of the three tubes, one-dimensional projections 
(gradient echo) were acquired following non-selective 10° flip angle pulses applied 
every 20 s. Gradient strength was adjusted to maximize the signal per voxel while 
avoiding overlap between the signal originating from the three different tubes in the 
one-dimensional projection. In all measurements, the persistent radical which is 
necessary for the DNP process was scavenged with sodium ascorbate prior to the 
infusion of the hyperpolarized solution into the tubes (19). The 
6
Li decay curves were 
obtained from each experiment by plotting the magnitude of the signal corresponding 
to each tube as a function of time (Fig. 2). The characteristic decay constants were 
obtained by fitting the curves with mono-exponential functions. The longitudinal 
relaxation time T1 was deduced after correcting for the effect of the pulses on the 
signal decay. The 
6
Li T1 values measured in blood and plasma samples are presented 
in Table 1. 
To evaluate the effect of the radical scavenger on 
6
Li T1, measurements were 
performed in thermally polarized 0.5 M 
6
LiCl aqueous solutions (D2O, 99.6% D) with 
or without scavenger (Table 2). The T1 in pure non-deoxygenated D2O (99.98 % D) 
was similar to the previously reported value for deoxygenated D2O (15). Adding 20 
mM of sodium ascorbate, either in its protonated or deuterated form, led to a decrease 
5 
in T1 of about 20 %. Although the exchangeable protons of ascorbate increase the 
concentration of protonated water molecules and therefore participate in increasing 
the solvent-induced dipolar relaxation of 
6
Li (20), the fact that the T1 was nearly 
identical when ascorbate was deuterated shows that the most prominent relaxation 
mechanism induced by the presence of ascorbate is rather due to a direct interaction 
between Li
+
 ions and ascorbate (a complete analysis of the relaxation mechanism is 
however beyond the scope of the present study). When performing hyperpolarized 
6
Li 
MR experiments, it was observed that an ascorbate-to-radical ratio of 3 was 
insufficient to rapidly scavenge the 0.4 mM of nitroxyl radical present in the final 
solution since a substantially shorter T1 was recorded (Table 2). In a second series of 
experiments performed with a drastically lower radical concentration corresponding 
to an ascorbate-to-radical ratio of 30 for an ascorbate concentration of 0.45 mM, the 
contribution of nitroxyl radicals to the 
6
Li relaxation was effectively quenched and 
essentially negligible. 
Two parameters were measured to assess the efficiency of the deoxygenation 
procedure: the partial pressure of oxygen (PO2), representative of the concentration 
free oxygen gas dissolved in the sample, as well as the oxygen saturation (SO2), 
indicating the fraction of hemoglobin bound to oxygen. The relative decrease in PO2 
following deoxygenation, namely ([PO2]
oxy
-[PO2]
deoxy
)/ [PO2]
oxy
, was 5.2% in blood 
and 36% in plasma, and a relative reduction of ([SO2]
oxy
-[SO2]
deoxy
)/ [SO2]
oxy 
= 2% 
was measured in blood (Table 3). 
The relative change in 
6
Li longitudinal relaxation time following deoxygenation, 
namely (T1
oxy
-T1
deoxy
)/ T1
oxy
, was computed for each experiment (Fig. 3). We 
observed in all experiments that the 
6
Li T1 is shorter in deoxygenated blood than in 
whole blood, i.e., partially oxygenated blood, with a mean relative variation between 
10 and 15%. Conversely, the observed 
6
Li T1 is longer in deoxygenated plasma than 
in partially oxygenated plasma. To confirm these results at pharmacologically 
relevant lithium level in anticipation of future in vivo studies, a series of experiment 
6 
was carried out in rat blood and plasma using deuterated phosphate buffer instead of 
D2O for dissolution. The same trend was observed with a relative change of + 10.5 % 
in rat blood and -6.5% in the plasma following deoxygenation. In this second series of 
experiments, the standard deviation on the relative differences was significantly lower 
(less than 10%). 
DISCUSSION 
The present study shows that hemoglobin oxygenation can be monitored through its 
influence on the hyperpolarized 
6
Li longitudinal relaxation time. We chose to add 
ascorbate in the hyperpolarized 
6
Li solutions not only to reduce the detrimental effect 
of the TEMPOL (4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl) radicals on the 
relaxation and therefore increase the T1, but also to improve the reproducibility of the 
experiments since even slight changes in radical concentration can have a strong 
effect on the long 
6
Li relaxation time. As was already observed with hyperpolarized 
[1-
13
C]acetate (20), a relatively large ascorbate-to-radical concentration ratio must be 
used to completely quench the radicals within the short hyperpolarized MR 
experiments. However, increasing the scavenger concentration above a certain 
threshold will also lead to increased relaxation induced by the presence of ascorbate 
molecules. A possible way to avoid this issue would be to use radicals such as BDPA 
(1,3-bisdiphenylene-2-phenylallyl), which can be easily filtered out since they 
precipitate in aqueous solutions (21). 
Oxygenated hemoglobin being diamagnetic, it does not affect the 
6
Li relaxation. By 
blowing argon gas on whole blood samples, oxyhemoglobin was transformed into 
deoxyhemoglobin. The shorter 
6
Li T1 observed in deoxygenated blood as compared to 
non-deoxygenated blood was ascribed to paramagnetic deoxyhemoglobin. The 
relative (T1
oxy
-T1
deoxy
)/ T1
oxy
 ratio in 
6
Li longitudinal relaxation time are therefore 
positive in blood samples (Fig. 3). This effect is similar to the BOLD contrast which 
originates from the change in proton T2
*
 induced by the paramagnetic relaxation 
7 
caused by the presence of deoxyhemoglobin. In contrast, in plasma, oxygen is present 
as molecular O2 which is paramagnetic. Blowing argon removes O2 thereby reducing 
the concentration of paramagnetic species from the plasma and leading to increased 
6
Li T1 values. The relative (T1
oxy
-T1
deoxy
)/ T1
oxy
 ratio is therefore negative in plasma 
(Fig. 3). 
A non-negligible variability in the 
6
Li T1 values measured in blood and plasma 
samples was observed, in particular in experiments performed in the first series of 
experiments (Table 1). These variances were dramatically reduced in the second 
series of experiments performed with pharmacological doses of lithium and 
substantially longer T1 values were recorded in the plasma samples. These two 
observations led us to conclude once more that a large scavenger-to-radical is 
necessary to limit the effect of the unavoidable slight variations in radical 
concentration on T1 and, while in blood samples the contribution of deoxyhemoglobin 
to the 
6
Li longitudinal relaxation is dominant, the nitroxyl radicals seem to be a non-
negligible relaxation mechanism in plasma samples. 
It also appear that the mean relative (T1
oxy
-T1
deoxy
)/ T1
oxy
 ratio measure in blood 
samples is rather similar in all experiments, ranging from 10.5 to 15%, whereas it 
varies from -6.5 to -20.5% in the plasma samples. This can be explained by the 
strikingly high variability in plasma PO2 following the deoxygenation procedure even 
within the same series of experiments (see Table 3). In addition, the blood and plasma 
samples used in the second series were more diluted than in the first series of 
experiments following the injection of 400uL of hyperpolarized 
6
Li in 1.5 mL of 
samples instead of 300uL of hyperpolarized 
6
Li in 2 mL samples (see Experimental 
section). The oxygen concentration was therefore expected to be higher in the first 
series of experiments, meaning that a stronger effect of plasma deoxygenation could 
be expected.  
8 
When comparing the relative changes in T1 measured in the second series of 
experiments with the results of the gas analyses, it appears that a 2% variation in 
blood oxygen level translate into a 10.5% change in 
6
Li T1, demonstrating the high 
sensitivity of the proposed method. Note that a relative variation of 36% in PO2 
measured in plasma only corresponds to a 6.5% change in T1, showing that the 
relaxation of 
6
Li is remarkably more sensitive to the presence of deoxyhemoglobin 
than of molecular oxygen. 
In a medical context, the primary use of lithium salts is to treat manic-depressive 
(bipolar) and depressive disorders (22,23). They have been administrated at doses up 
to 1200 mg/day, which led to serum concentration between 0.3-1 mM (24), a range 
which is similar to the concentration obtained after infusion of hyperpolarized [1-
13
C]pyruvate in the first clinical study (25). We show that blood oxygenation can be 
monitored through its influence on the hyperpolarized 
6
Li longitudinal relaxation time 
also when using pharmacological lithium doses. The observed difference in T1 
between whole and deoxygenated blood could therefore be possibly used to detect 
hemoglobin oxygenation level in vivo. Due to the ability of Li
+
 ions to diffuse freely 
across cell membranes, T1-weighted 
6
Li imaging could be considered to obtain 
oxygenation maps. This would be a particularly interesting diagnostic tool for 
assessing tumor oxygenation level, for instance prior to radiation therapy. It must, 
however, be borne in mind that the intracellular and extracellular 
6
Li T1 might be 
substantially different and the interpretation of the results could intricate. 
EXPERIMENTAL 
Fresh human venous blood samples were provided by healthy volunteers. Rat venous 
blood samples were collected by bleeding 10 male Sprague-Dawley rats (384 ± 40 g). 
Rats were anesthetized with 1.5% isoflurane in a 30% O2/70% N2O mixture. All 
animal experiments were performed according to Federal and local ethical guidelines, 
and the protocols were approved by the local regulatory body (Service de la 
9 
consommation et des affaires vétérinaires, Affaires vétérinaires, Canton de Vaud, 
Suisse).  3 UI/mL of heparin (Drossapharm AGSG, Basel, Switzerland) was added to 
each human and animal blood samples.  Samples were kept refrigerated at 5°C in 50 
mL Falcon tubes and were used within two days following blood withdrawal. Plasma 
was extracted from blood samples following natural phase separation in tubes stored 
in vertical position at 5°C. 
MR measurements were carried out on an actively-shielded horizontal 9.4 T / 31 cm 
animal scanner (Varian/Magnex, Palo Alto, CA, USA) using a custom-designed 
1
H / 
6
Li probe based on two stacked 40-mm inner diameter coils (machined from a double-
sided printed circuit board) surrounding a cylindrical tube holder (Plexiglass) 
containing three 10-mm diameter glass tubes, two with thin 0.55-mm walls (513-1PS-
7, Wilmad, Vineland, NJ, USA) and one with 1.45-mm wall thickness (513-7PPH-7, 
Wilmad, Vineland, NJ, USA). The geometry of the tube holder was designed so that 
the horizontal tomographic projection of each of the three tubes is well separated from 
one another (Fig. 1). In all experiments the tube holder was inserted inside the magnet 
bore prior to each dissolution DNP experiment. Proton images were acquired to 
position the tube holder at the magnet isocenter and static field inhomogeneities were 
corrected by manual shimming. The deoxygenation process consisted in blowing 
argon gas inside the glass tube containing either blood or plasma for 10 min, about 5 
min prior to the dissolution experiment. Heavy noble gas was preferred over nitrogen 
gas to prevent air from reoxygenating the samples before and during MR acquisitions. 
Each tube was then covered with a perforated plastic cap. A polytetrafluoroethylene 
(PTFE) capillary was inserted through the cap to remotely inject the hyperpolarized 
6
Li
+
 solution into the sample. 
A first series of experiments was performed in both human and rat blood using a 
6
Li
+
 
concentration of 130 mM. A set of three 2-mL samples each inserted in one glass tube 
were probed: tube #1 and tube #3 contained either whole blood and deoxygenated 
blood or plasma and deoxygenated plasma. Tube #2 was filled with pure D2O and 
10 
served as reference to assess the relaxation time of each hyperpolarized 
6
Li
+
 solution. 
Prior to each experiment, 350 μL of 15 M 6LiCl solution prepared  in 2:1 D2O/d6-
ethanol (v/v) doped with 40 mM TEMPOL was inserted, in the form of 2-mm 
diameter frozen beads, inside a custom-designed 7 T polarizer (26). 50 μL of frozen 1 
M aqueous sodium ascorbate solution was added inside the sample cup to scavenge 
the TEMPOL radicals during the dissolution process (19). All chemicals were 
purchased from Sigma-Aldrich (Buchs, Switzerland). After 1 h of polarization at 
1±0.05 K, the samples were rapidly dissolved in 5 mL of superheated D2O (180ºC) 
and the resulting hyperpolarized 
6
Li
+
 solution was collected out of the polarizer by 
blowing high-pressure helium gas (6 bar) for 3.5 s through the dissolution insert 
previously described (27). 300 μL of solution was manually and sequentially injected 
into each 10 mm-tube through a PTFE  capillary within 10 s. Data acquisition started 
20 s after dissolution. The liquid-state 
6
Li polarization at the time of measurements 
was estimated to be 5±0.3% from a comparison between the hyperpolarized and the 
thermally polarized 
6
Li signals. 
To confirm these observations at pharmacologically relevant Li
+
 level, a second series 
of experiments was performed in rat blood and plasma. For these experiments, tube 
#1 and tube #3 were filled with 1.5 mL of either whole blood and deoxygenated blood 
or plasma and deoxygenated plasma. Tube #2 was filled with 1.5 mL of pure D2O. An 
amount of 5 μL of 3 M 6LiCl frozen solution prepared in 1:1 D2O/glycerol-d8 (w/w) 
doped with 58 mM TEMPOL was inserted inside the polarizer along with 10 μL of 
frozen 1 M aqueous sodium ascorbate solution. The concentration of lithium salt was 
reduced from 15 M to 3 M to avoid inaccuracy in sample volume when preparing the 
frozen beads. Polarization time was set to 1.5 h and the samples were dissolved in 5 
mL of superheated deuterated phosphate buffer. The liquid-state 
6
Li polarization was 
7.4±0.5%. After having collected the hyperpolarized 
6
Li
+
 solution, 400 μL of solution 
was manually and sequentially injected prior to data acquisition. The other parameters 
were identical to the ones set in the first series of experiments. 
11 
In conjunction with the hyperpolarized 
6
Li MR experiments, oxygen gas analysis was 
performed in samples prepared in the exact same way than those used in the second 
series of experiments.  For these analyses, 100 L aliquots of blood or plasma were 
taken from each sample and the PO2 and SO2 values were obtained using a COBAS
® 
b 121 system (Roche Diagnostic GmbH, Mannhelm, Germany). 
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Figure legends 
Figure 1. Left: Schematic representation of the tube holder containing the three 10-
mm glass tubes labeled from 1 to 3 and the surrounding 40-mm inner diameter coils. 
Tube #2 has thicker walls and served as reference to assess the relaxation time of each 
hyperpolarized 
6
Li
+
 solution. Tubes #1 and #3 served for the relative measurements 
between whole and deoxygenated blood or plasma; Right: Cross section showing the 
arrangement of the three tubes inside the tube holder. 
Figure 2. Top: Time evolution of the tomographic projection of the 
6
Li signal 
measured following the simultaneous injection of hyperpolarized 
6
Li
+
 solution into all 
three tubes. Projections were acquired along the horizontal axis perpendicular to the 
static field using a 2.5-ms 6-G/cm dephasing gradient and a 20-ms 1.5-G/cm  
acquisition gradient. Bottom: Integral of the projected 
6
Li signal measured in tubes 
#1 to #3 as a function of time. 
Figure 3. Mean relative change in 
6
Li longitudinal relaxation time after 
deoxygenation of blood and plasma in both human and rat samples.  
Table 1. Mean 
6
Li longitudinal relaxation time measured in human and rat samples 
displayed with their standard deviation (SD) and relative standard deviation (RSD). 
Table 2. Longitudinal relaxation time of 
6
Li in various aqueous solutions. The 
measurements were performed on a 400 MHz high-resolution MR system (Bruker 
Biospin, Fällanden, Switzerland) using a saturation recovery protocol. 
Table 3. Results of the oxygen gas analysis in blood and plasma samples. The 
measurements were performed using a COBAS
®
 b 121 system (Roche Diagnostic 
GmbH, Mannhelm, Germany). 
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Table 1 
Human samples 
(130 mM 
6
Li, n = 3) 
6
Li T1 (s) SD (s) RSD (%) 
Whole blood  
Deoxygenated blood 
Plasma 
Deoxygenated plasma 
177 
157 
115 
135 
31 
28 
7 
10 
17.5 
17.8 
6.1 
7.4 
Rat samples  
(130 mM 
6
Li, n = 3) 
   
Whole blood 
Deoxygenated blood 
Plasma 
Deoxygenated plasma 
180 
153 
103 
123 
19 
12 
7 
5 
10.5 
7.8 
6.8 
4.0 
Rat samples  
(0.65 mM 
6
Li, n = 4) 
   
Whole blood 
Dexoygenated blood 
Plasma 
Deoxygenated plasma 
161 
144 
137 
146 
2 
2 
4 
5 
1.2 
1.4 
2.9 
3.4 
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Table 2 
 
Sample composition 
6
Li T1 (s) 
0.5 M 
6
LiCl in pure D2O 506 ± 10 
0.5 M 
6
LiCl in D2O with 20 mM deuterated sodium ascorbate 401 ± 5 
0.5 M 
6
LiCl in D2O with 20 mM sodium ascorbate 394 ± 5 
Hyperpolarized 
6
LiCl solution (n=6) 
(130 mM 
6
Li in D2O containing 1.2 mM ascorbate and 0.4 mM TEMPOL) 
261 ± 5 
Hyperpolarized 
6
LiCl solution (n=8) 
(0.65 mM 
6
Li in deuterated phosphate buffer containing 0.45 mM ascorbate 
and 0.015 mM TEMPOL) 
413 ± 15 
    
  
21 
Table 3 
 
Samples 
(n = 3) 
PO2 
(mmHg) 
SD (mmHg) RSD (%) 
Whole blood 
Dexoygenated blood 
Plasma 
Deoxygenated plasma 
45.9 
43.5 
121.7 
77.9 
0.6 
0.5 
1.2 
13.4 
1.3 
1.1 
1.0 
17.2 
Samples 
(n = 3) 
SO2 (%) SD (%) RSD (%) 
Whole blood 
Dexoygenated blood 
76.9 
75.4 
0.3 
0.7 
0.4 
0.9 
 
